About the Authors
- Tomer Hertz
-
* E-mail: thertz@fhcrc.org
Affiliation Statistical Center for HIV Research and Prevention, Vaccine and Infectious Disease Division and the HIV Vaccine Trials Network, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
- Hasan Ahmed
-
Affiliation Statistical Center for HIV Research and Prevention, Vaccine and Infectious Disease Division and the HIV Vaccine Trials Network, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
- David P. Friedrich
-
Affiliation Statistical Center for HIV Research and Prevention, Vaccine and Infectious Disease Division and the HIV Vaccine Trials Network, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
- Danilo R. Casimiro
-
Affiliation Merck Research Laboratories, West Point, Pennsylvania, United States of America
- Steven G. Self
-
Affiliation Statistical Center for HIV Research and Prevention, Vaccine and Infectious Disease Division and the HIV Vaccine Trials Network, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
- Lawrence Corey
-
Affiliation Statistical Center for HIV Research and Prevention, Vaccine and Infectious Disease Division and the HIV Vaccine Trials Network, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
- M. Juliana McElrath
-
Affiliation Statistical Center for HIV Research and Prevention, Vaccine and Infectious Disease Division and the HIV Vaccine Trials Network, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
- Susan Buchbinder
-
Affiliation HIV Research Section, San Francisco Department of Public Health, San Francisco, California, United States of America
- Helen Horton
-
Affiliation Viral Vaccine Program, Seattle Biomedical Research Institute, Seattle, Washington, United States of America
- Nicole Frahm
-
Affiliation Statistical Center for HIV Research and Prevention, Vaccine and Infectious Disease Division and the HIV Vaccine Trials Network, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
- Michael N. Robertson
-
Affiliation Merck Research Laboratories, West Point, Pennsylvania, United States of America
- Barney S. Graham
-
Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
- Peter Gilbert
-
Affiliation Statistical Center for HIV Research and Prevention, Vaccine and Infectious Disease Division and the HIV Vaccine Trials Network, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
Competing Interests
M. N. R. and D.R.C. are paid employees of Merck & Co., Inc. and own stock in Merck. This does not alter our adherence to all PLOS Pathogens policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: TH PG SGS. Performed the experiments: TH HA DPF HH NF. Analyzed the data: TH HA. Contributed reagents/materials/analysis tools: DRC BSG MNR NF HH DPF. Wrote the paper: TH HA LC DPF DRC HH MJM SB NF BSG PG.